Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
130M
-
Number of holders
-
308
-
Total 13F shares, excl. options
-
111M
-
Shares change
-
+4.24M
-
Total reported value, excl. options
-
$5.03B
-
Value change
-
+$185M
-
Put/Call ratio
-
0.74
-
Number of buys
-
138
-
Number of sells
-
-151
-
Price
-
$45.17
Significant Holders of NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) as of Q2 2021
373 filings reported holding NEO - NEOGENOMICS INC - Common Stock, par value $0.001 per share as of Q2 2021.
NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) has 308 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 111M shares
of 130M outstanding shares and own 85.87% of the company stock.
Largest 10 shareholders include BlackRock Inc. (18.7M shares), VANGUARD GROUP INC (12.2M shares), WELLINGTON MANAGEMENT GROUP LLP (5.55M shares), Artisan Partners Limited Partnership (4.84M shares), Invesco Ltd. (4.49M shares), JANUS HENDERSON GROUP PLC (4.43M shares), STATE STREET CORP (3.49M shares), BROWN ADVISORY INC (3.31M shares), AMERIPRISE FINANCIAL INC (2.48M shares), and FRED ALGER MANAGEMENT, LLC (2.03M shares).
This table shows the top 308 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.